MedPath

Observation study for neuroblastoma using cell-free DNA in serum

Not Applicable
Conditions
neuroblastoma
Registration Number
JPRN-UMIN000019894
Lead Sponsor
Japan Neuroblstoma Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with life-threatening symptoms associated with tumor growth 2) Catecholamine secreting neuroblastoma patiets 3)physician determines patients unsuitable to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression-free survival period
Secondary Outcome Measures
NameTimeMethod
therapeutic intervention period, ratio of the tumor progression cases
© Copyright 2025. All Rights Reserved by MedPath